Trials / Unknown
UnknownNCT01196884
Immune Thrombocytopenia (ITP) Immune-Genetic Assessment
IMMUNE-GENETIC ASSESSMENT OF PRIMARY ITP IN ADULT
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 190 (estimated)
- Sponsor
- Azienda Sanitaria-Universitaria Integrata di Udine · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Primary ITP has wide heterogenous biology, presentation and response to therapy. The immune-genetic assessment of ITP may help to identify differences among patients with ITP and optimize the therapeutic choice.
Conditions
Timeline
- Start date
- 2010-09-01
- First posted
- 2010-09-09
- Last updated
- 2018-03-20
Locations
13 sites across 1 country: Italy
Source: ClinicalTrials.gov record NCT01196884. Inclusion in this directory is not an endorsement.